mk 0591 has been researched along with Acute Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bukhave, K; Depré, M; Friedman, BS; Hillingsø, J; Kjeldsen, J; Lauritsen, K; Laursen, LS; Malmström, K; Shingo, S; von Spreckelsen, S | 1 |
Boros, V; Burghardt, JS; Morgan, CJ; Olson, DM | 1 |
1 trial(s) available for mk 0591 and Acute Disease
Article | Year |
---|---|
Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitis.
Topics: Acute Disease; Administration, Oral; Adult; Colitis, Ulcerative; Dinoprostone; Double-Blind Method; Female; Humans; Indoles; Leukotriene B4; Male; Middle Aged; Quinolines | 1995 |
1 other study(ies) available for mk 0591 and Acute Disease
Article | Year |
---|---|
Leukotrienes are indicated as mediators of hyperoxia-inhibited alveolarization in newborn rats.
Topics: Acute Disease; Animals; Animals, Newborn; Arachidonate 5-Lipoxygenase; Body Weight; Female; Hyperoxia; In Vitro Techniques; Indoles; Leukotrienes; Lipoxygenase Inhibitors; Lung; Lung Injury; Male; Naphthaleneacetic Acids; Pulmonary Alveoli; Quinolines; Rats; Rats, Sprague-Dawley; Time Factors | 1997 |